These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 4445766)
1. [Current immunologic data on Hodgkin's disease]. Weisgerber C; Kourilsky FM Rev Prat; 1974 Oct; 24(45):3927-9. PubMed ID: 4445766 [No Abstract] [Full Text] [Related]
2. [Immunological competence in Hodgkin's disease]. Lang JM Pathol Biol (Paris); 1973 Mar; 21(3):285-97. PubMed ID: 4145143 [No Abstract] [Full Text] [Related]
3. Invited discussion: kinetic approach to the study of cell-mediated immunity in Hodgkin's disease. Hersh EM Natl Cancer Inst Monogr; 1973 May; 36():123-4. PubMed ID: 4744573 [No Abstract] [Full Text] [Related]
5. Zoster and Hodgkin's disease. Br Med J; 1972 Jul; 3(5819):130-1. PubMed ID: 5039773 [No Abstract] [Full Text] [Related]
6. Immunodeficiencies in Hodgkin's disease. Part I: T cell-mediated immunity. Gupta S Clin Bull; 1981; 11(2):58-65. PubMed ID: 6459892 [TBL] [Abstract][Full Text] [Related]
7. Immunologic deficiency in Hodgkin's disease. Sokal JE Tumori; 1973; 59(5):343-50. PubMed ID: 4360756 [No Abstract] [Full Text] [Related]
8. [Disturbance of the cellular defense in sarcoidosis]. Kohout J Med Klin; 1971 Dec; 66(51):1765-9. PubMed ID: 5135974 [No Abstract] [Full Text] [Related]
9. Immunological reactions to tumor-associated antigens in Burkitts lymphoma and other lymphomas. Herberman RB; McCoy JL; Levine PH Cancer Res; 1974 May; 34(5):1222-7. PubMed ID: 4366992 [No Abstract] [Full Text] [Related]
10. [Immunologic deficit in Hodgkin's disease. Clinical reflections and pathogenetic implications]. Maggi E; Romagnani S; Ricci M Ann Ital Med Int; 1986 Mar; 1(1):54-65. PubMed ID: 3079355 [No Abstract] [Full Text] [Related]
11. International Symposium on Hodgkin's disease. Session 1. Epidemiology and etiology. Part 4. Synthesis and epidemiological implications. Invited discussion: Synthesis and epidemiologic implications. Miller RW Natl Cancer Inst Monogr; 1973 May; 36():171-2. PubMed ID: 4270377 [No Abstract] [Full Text] [Related]
13. The macrophage aggregation assay for cell-mediated immunity in man. Studies of patients with Hodgkin's disease and sarcoidosis. Gotoff SP; Lolekha S; Lopata M; Kopp J; Kopp RL; Malecki TJ J Lab Clin Med; 1973 Oct; 82(4):682-91. PubMed ID: 4585463 [No Abstract] [Full Text] [Related]
14. [Clinical significance of the transfer factor]. Mutz I; Humphrey GB Wien Klin Wochenschr; 1973 May; 85(20):357-60. PubMed ID: 4574399 [No Abstract] [Full Text] [Related]
15. International symposium on Hodgkin's disease. Session I. Epidemiology and etiology. Part 3. Immunology. Introduction. Good RA Natl Cancer Inst Monogr; 1973 May; 36():93-4. PubMed ID: 4582999 [No Abstract] [Full Text] [Related]
16. [Modification of the immune state in Hodgkin's disease (study and prognostic value)]. Bernadou A; Weill B; Dao C; Bilski-Pasquier G Nouv Rev Fr Hematol Blood Cells; 1977; 18(1):162-3. PubMed ID: 331244 [No Abstract] [Full Text] [Related]
18. Delayed cutaneous hypersensitivity and blood lymphocyte count in advanced Hodgkin's and non-Hodgkin's lymphomas. Gupta S; Seth SK; Udupa KN; Sen PC; Rastogi BL Ann Chir Gynaecol; 1980; 69(2):79-83. PubMed ID: 7377739 [TBL] [Abstract][Full Text] [Related]
19. Blastogenic transformation of lymphocytes following phytohaemagglutinin treatment in vitro in malignant lymphomas. I. Hodgkin's disease. (Correlation with immunity response of the cellular type and with the clinical status). Libánský J; Lukásová M; Pinosová I Neoplasma; 1973; 20(1):51-60. PubMed ID: 4702205 [No Abstract] [Full Text] [Related]